- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Most Viewed Articles About PBMs
Pharmacy benefit managers (PBMs) were in the news in 2022, and Managed Healthcare Executive®’s coverage of PBMs garnered a great deal of attention.
Beyond the Big Three PBMs
Smaller and midsize pharmacy benefit managers are taking on Optum Rx, CVS Caremark and Express Scripts. They say they have better technology and are more transparent about their pricing.
PBMs are Creating GPOs, and Stirring Debate as to Why
The Big Three all set up group purchasing organizations recently, but some industry observers question the timing of the move and who will benefit.
Large Employers Launch PBM
EmsanaRx, a pharmacy benefit manager launched by the Purchaser Business Group on Health, started operations in January 2022
2022 PBMI National Meeting Kicks Off Monday
Agenda includes sessions on overall trends in the pharmacy benefit management industry, digital therapeutics and biosimilars.
A Conversation with Alan Lotvin, M.D. on the PBM Industry’s Reputation | Part 1
The president of CVS Caremark discusses the PBM industry’s reputation, list prices and rebates.
